Antibiotic-associated colitis.
D000667:Ampicillin / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002981:Clindamycin / Q000009:adverse effects; D003013:Clostridium / Q000302:isolation & purification; D003015:Clostridium Infections / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D003092:Colitis / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D003113:Colonoscopy; D003967:Diarrhea / Q000209:etiology / Q000503:physiopathology; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced / Q000473:pathology / Q000628:therapy; D004768:Enterotoxins / Q000032:analysis; D005243:Feces / Q000382:microbiology; D005440:Fluid Therapy; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D012008:Recurrence; D013203:Staphylococcal Infections / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004768:Enterotoxins; D002792:Cholestyramine Resin; D008795:Metronidazole; D002981:Clindamycin; D014640:Vancomycin; D000667:Ampicillin